Literature DB >> 26938201

Mechanisms Linking the Gut Microbiome and Glucose Metabolism.

Kristina M Utzschneider1, Mario Kratz1, Chris J Damman1, Meredith Hullar1.   

Abstract

This review details potential mechanisms linking gut dysbiosis to metabolic dysfunction, including lipopolysaccharide, bile acids, short chain fatty acids, gut hormones, and branched-chain amino acids.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26938201      PMCID： PMC4880177          DOI： 10.1210/jc.2015-4251

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


  118 in total

1.  The bile acid sensor FXR regulates insulin transcription and secretion.

Authors:  Barbara Renga; Andrea Mencarelli; Piero Vavassori; Vincenzo Brancaleone; Stefano Fiorucci
Journal:  Biochim Biophys Acta       Date:  2010-01-07

2.  Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.

Authors:  Tannaz Eslamparast; Hossein Poustchi; Farhad Zamani; Maryam Sharafkhah; Reza Malekzadeh; Azita Hekmatdoost
Journal:  Am J Clin Nutr       Date:  2014-01-08       Impact factor: 7.045

3.  Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons.

Authors:  Anita C E Vreugdenhil; Corine H Rousseau; Thomas Hartung; Jan Willem M Greve; Cornelis van 't Veer; Wim A Buurman
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

4.  Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers.

Authors:  Francesco Russo; Michele Linsalata; Caterina Clemente; Marisa Chiloiro; Antonella Orlando; Emanuele Marconi; Guglielmina Chimienti; Giuseppe Riezzo
Journal:  Nutr Res       Date:  2012-11-17       Impact factor: 3.315

5.  Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.

Authors:  Sunder Mudaliar; Robert R Henry; Arun J Sanyal; Linda Morrow; Hanns-Ulrich Marschall; Mark Kipnes; Luciano Adorini; Cathi I Sciacca; Paul Clopton; Erin Castelloe; Paul Dillon; Mark Pruzanski; David Shapiro
Journal:  Gastroenterology       Date:  2013-05-30       Impact factor: 22.682

6.  Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men.

Authors:  Alena Stancáková; Mete Civelek; Niyas K Saleem; Pasi Soininen; Antti J Kangas; Henna Cederberg; Jussi Paananen; Jussi Pihlajamäki; Lori L Bonnycastle; Mario A Morken; Michael Boehnke; Päivi Pajukanta; Aldons J Lusis; Francis S Collins; Johanna Kuusisto; Mika Ala-Korpela; Markku Laakso
Journal:  Diabetes       Date:  2012-05-02       Impact factor: 9.461

Review 7.  Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome.

Authors:  Nathalie M Delzenne; Audrey M Neyrinck; Patrice D Cani
Journal:  Microb Cell Fact       Date:  2011-08-30       Impact factor: 5.328

8.  Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus.

Authors:  Carine Steiner; Alaa Othman; Christoph H Saely; Philipp Rein; Heinz Drexel; Arnold von Eckardstein; Katharina M Rentsch
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

Review 9.  The environment within: how gut microbiota may influence metabolism and body composition.

Authors:  A Vrieze; F Holleman; E G Zoetendal; W M de Vos; J B L Hoekstra; M Nieuwdorp
Journal:  Diabetologia       Date:  2010-01-26       Impact factor: 10.122

10.  Small intestinal permeability in older adults.

Authors:  Luzia Valentini; Sara Ramminger; Verena Haas; Elisa Postrach; Martina Werich; André Fischer; Michael Koller; Alexander Swidsinski; Stefan Bereswill; Herbert Lochs; Jörg-Dieter Schulzke
Journal:  Physiol Rep       Date:  2014-04-22
View more
  47 in total

Review 1.  Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk.

Authors:  Allison B Goldfine; Steven E Shoelson
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice.

Authors:  Shogo Takahashi; Yuhuan Luo; Suman Ranjit; Cen Xie; Andrew E Libby; David J Orlicky; Alexander Dvornikov; Xiaoxin X Wang; Komuraiah Myakala; Bryce A Jones; Kanchan Bhasin; Dong Wang; James L McManaman; Kristopher W Krausz; Enrico Gratton; Diana Ir; Charles E Robertson; Daniel N Frank; Frank J Gonzalez; Moshe Levi
Journal:  J Biol Chem       Date:  2020-02-19       Impact factor: 5.157

3.  Understanding the Interaction of Diet Quality with the Gut Microbiome and Their Effect on Disease.

Authors:  Gertraud Maskarinec; Meredith A J Hullar
Journal:  J Nutr       Date:  2020-04-01       Impact factor: 4.798

Review 4.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

Review 5.  Interorgan crosstalk in pancreatic islet function and pathology.

Authors:  Ronald M Evans; Zong Wei
Journal:  FEBS Lett       Date:  2022-01-19       Impact factor: 4.124

6.  Physiologic colonic uptake of 18F-FDG on PET/CT is associated with clinical response and gut microbiome composition in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors.

Authors:  Lena Cvetkovic; Claudine Régis; Corentin Richard; Lisa Derosa; Antoine Leblond; Julie Malo; Meriem Messaoudene; Antoine Desilets; Wiam Belkaid; Arielle Elkrief; Bertrand Routy; Daniel Juneau
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-31       Impact factor: 9.236

7.  The human gut microbiome and health inequities.

Authors:  Katherine R Amato; Marie-Claire Arrieta; Meghan B Azad; Michael T Bailey; Josiane L Broussard; Carlijn E Bruggeling; Erika C Claud; Elizabeth K Costello; Emily R Davenport; Bas E Dutilh; Holly A Swain Ewald; Paul Ewald; Erin C Hanlon; Wrenetha Julion; Ali Keshavarzian; Corinne F Maurice; Gregory E Miller; Geoffrey A Preidis; Laure Segurel; Burton Singer; Sathish Subramanian; Liping Zhao; Christopher W Kuzawa
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205

8.  Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex.

Authors:  Alexandra G Yunker; Shan Luo; Sabrina Jones; Hilary M Dorton; Jasmin M Alves; Brendan Angelo; Alexis DeFendis; Trevor A Pickering; John R Monterosso; Kathleen A Page
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

9.  Taxonomic signatures of cause-specific mortality risk in human gut microbiome.

Authors:  Aaro Salosensaari; Ville Laitinen; Leo Lahti; Teemu Niiranen; Aki S Havulinna; Guillaume Meric; Susan Cheng; Markus Perola; Liisa Valsta; Georg Alfthan; Michael Inouye; Jeramie D Watrous; Tao Long; Rodolfo A Salido; Karenina Sanders; Caitriona Brennan; Gregory C Humphrey; Jon G Sanders; Mohit Jain; Pekka Jousilahti; Veikko Salomaa; Rob Knight
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 10.  Microbiome distinctions between the CRC carcinogenic pathways.

Authors:  Lauren DeDecker; Bretton Coppedge; Julio Avelar-Barragan; William Karnes; Katrine Whiteson
Journal:  Gut Microbes       Date:  2021-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.